EDIT vs PFG · rev $32.3M vs P/E 16, rev $16.13B
Editas Medicine Inc (EDIT) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PFG revenue for 2024-12-31 was $16.13B. Net income was $1.60B. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
EDIT currently screens at market cap $375.2M. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the EDIT and PFG stock pages for the full models.
Not investment advice.